Mohammed Khoso Baluch
Vorsitzender bei POXEL
Vermögen: 5 485 $ am 30.04.2024
Aktive Positionen von Mohammed Khoso Baluch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POXEL | Independent Dir/Board Member | 01.01.2012 | - |
Vorsitzender | 01.03.2023 | - | |
Direktor/Vorstandsmitglied | 01.01.2012 | 01.03.2023 | |
PROCESSA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 11.07.2022 | - |
Independent Dir/Board Member | 11.07.2022 | - | |
LONGEVERON INC. | Direktor/Vorstandsmitglied | 09.06.2023 | - |
Independent Dir/Board Member | 09.06.2023 | - |
Karriereverlauf von Mohammed Khoso Baluch
Ehemalige bekannte Positionen von Mohammed Khoso Baluch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Vorsitzender | 01.12.2021 | 01.11.2022 |
CORMEDIX INC. | Comptroller/Controller/Auditor | 31.01.2020 | 11.05.2020 |
Direktor/Vorstandsmitglied | 03.10.2016 | 04.10.2021 | |
Vorstandsvorsitzender | 03.10.2016 | 04.10.2021 | |
Finanzdirektor/CFO | 31.01.2020 | 11.05.2020 | |
UCB | Corporate Officer/Principal | 01.02.2013 | 01.04.2016 |
Vertrieb & Marketing | 01.01.2008 | 01.04.2016 | |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Direktor/Vorstandsmitglied | 01.01.2008 | 01.04.2016 |
Corporate Officer/Principal | 01.01.2008 | 01.04.2016 | |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.1984 | 01.07.2008 |
UCB AE | Vorsitzender | - | - |
░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░ ░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░ ░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░ ░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Mohammed Khoso Baluch
City University London | Undergraduate Degree |
Cranfield School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 8 |
Frankreich | 4 |
Vereinigtes Königreich | 4 |
Operativ
Director/Board Member | 7 |
Corporate Officer/Principal | 6 |
Chairman | 5 |
Sektoral
Health Technology | 10 |
Consumer Services | 3 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 6 |
---|---|
UCB | Health Technology |
POXEL | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
CORMEDIX INC. | Health Technology |
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
LONGEVERON INC. | Health Technology |
Private Unternehmen | 11 |
---|---|
Juvenile Diabetes Research Foundation of Arizona, Inc. | |
Vedim Pharma SA
Vedim Pharma SA Pharmaceuticals: MajorHealth Technology Part of UCB SA, Vedim Pharma SA is a French pharmaceutical company that manufactures pharmaceuticals. | Health Technology |
UCB Pharma SA
UCB Pharma SA Chemicals: SpecialtyProcess Industries UCB Pharma SA manufactures pharmaceutical products. It develops products in areas, such as epilepsy, central nervous system, immunology and inflammation. The company is headquartered in Molins de Rei, Spain | Process Industries |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Finance |
UCB Pharma AB | |
UCB Pharma AS | |
UCB Pharma Ltd.
UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom. | Health Technology |
UCB Pharma Sp zoo | |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Commercial Services |
UCB AE | |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Health Technology |
- Börse
- Insiders
- Mohammed Khoso Baluch
- Erfahrung